About DELTA CHASE LLC
Delta Chase LLC develops the SAGE Rebreather™, a device aimed at improving a range of health conditions by modulating CO2 levels. The company is focused on innovative medical technology solutions, though claims are not yet FDA authorized.
Development of medical devices for health condition managementCO2 modulation technology for multiple adverse human conditions
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I TOPIC A254-P039, XTECHSEARCH 9. | Department of Defense | $249K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DELTA CHASE LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.